1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. THERAVANCE BIOPHARMA INC
Theravance Biopharma Inc XNAS: TBPH

Theravance Biopharma Inc Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient...

Read More
18.49 0.45 (2.49%)
New 52W High in past week
601.9K
XNAS Volume

XNAS 18 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
33.0 / 100
Momentum Score
Technically Bullish
75.7 / 100
Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM
Analyst Price Target
22
1Yr Price target upside is 16%
6 analysts

25

S

10

W

2

O

3

T

SWOT Analysis

Theravance Biopharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..